A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy

N/ACompletedNCT02096484

University of Manchester40 enrolled

Overview

The study will examine the effectiveness of group metacognitive therapy in comparison with group meditation therapy, in patients with Generalised Anxiety Disorder. Individuals will be randomly assigned to either meditation or metacognitive therapy and undergo 8 group therapy sessions of their respective treatment condition.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Generalized Anxiety Disorder

Interventions

Group Metacognitive TherapyBEHAVIORAL

Mindfulness Meditation TherapyBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * individual's score on the GAD-7 \& PHQ-9 * individuals who meet the DSM-IV (Diagnostic and Statistical Manual) criteria for generalized anxiety disorder Exclusion Criteria: * Individuals with major depressive disorder * Individuals who report suicidality * Individuals with a brain injury or neurological insult * Individual who currently engage in substance abuse * Individuals with bipolar disorder * Individuals with psychotic symptoms * Individuals who cannot converse or read English

Locations (1)

The Rawnsley Building, Manchester Royal Infirmary, Oxford Road

Manchester, Lancashire, United Kingdom

Outcomes

Primary Outcomes

Hospital Anxiety and Depression Scale (HADS)

Time frame: Administered at pre treatment, mid treatment, post treatment, and 6 month follow up

Secondary Outcomes

CAS-I

Time frame: Administered at pre treatment, mid treatment, post treatment, and 6 month follow up

GAD-7

Time frame: Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of anxiety.

PHQ-9

Time frame: Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of depression.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.